Примери за използване на To thalidomide на Английски и техните преводи на Български
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Computer
Lenalidomide is structurally related to thalidomide.
Lenalidomide is structurally related to thalidomide, which is known to induce severe peripheral neuropathy.
Pomalidomide is structurally related to thalidomide.
The latter appears to be related to thalidomide and occurred at exposures greater than 2.4-fold the human exposure.
Pregnancy warning Lenalidomide is structurally related to thalidomide.
The name of the medicine was changed to Thalidomide Celgene on 22 October 2008.
Pregnancy(see also sections 4.3 and 4.4)Lenalidomide is structurally related to thalidomide.
Worldwide, over 10,000 cases of limb malformation connected to thalidomide were reported, with only 50% of children surviving.
Throughout the world, about 10,000 cases were reported of infants with phocomelia due to thalidomide;
This medicine is related to thalidomide and belongs to a group of medicines which affect the immune system(the body's natural defences).
Throughout the world, valium cheap prices about 10,000 cases were reported of infants with phocomelia due to thalidomide;
If you are allergic to thalidomide or any of the other ingredients of this medicine listed in section 6“Contents of the pack and other information”.
Throughout the world, about 10,000 cases were reported of infants with xanax no prescription phocomelia due to thalidomide;
The strict conditions put in place to prevent pregnancy andthe exposure of unborn children to thalidomide must be met by all men and women taking the medicine.
Throughout the world, about 10,000 cases were reported of infants with phocomelia due can you get phentermine online to thalidomide;
In addition to thalidomide, hydrolytic products N-(o-carboxybenzoyl) glutarimide and phthaloyl isoglutamine formed via non-enzymatic processes are also present in plasma and in majority in urine.
Throughout the world, about 10,000 buy sibutramine with mastercard cases were reported of infants with phocomelia due to thalidomide;
In order to assist patients in avoiding foetal exposure to thalidomide and to provide additional important safety information, the Marketing Authorisation holder will provide educational material to healthcare professionals.
Only 40% of these children survived.[4] Throughout the world, about 10,000 cases were reported of infants with phocomelia due to Thalidomide;
In addition to the adverse reactions notedin the pivotal study, adverse reactions related to thalidomide in combination with dexamethasone and also those based on post-marketing experience with the medicinal product are provided after Table 2.
This increase was not observed in clinical trials of newly diagnosed multiple myeloma in patients taking lenalidomide in combination with low dose dexamethasone compared to thalidomide in combination with melphalan and prednisone.
In order to assist patients in avoiding foetal exposure to thalidomide and to provide additional important safety information, the Marketing Authorisation holder will provide educational material to healthcare professionals.
Throughout the world around 10,000 children were born with phocomelia due to thalidomide and only half of them survived.
Due to thalidomide's potential to induce bradycardia, caution should be exercised with medicinal products having the same pharmacodynamic effect such as active substances known to induce torsade de pointes, beta blockers or anticholinesterase agents.
In order to assist patients in avoiding foetal exposure to thalidomide, the Marketing Authorisation Holder will provide educational material to healthcare professionals to reinforce the warnings about the teratogenicity of thalidomide, to provide advice on contraception before treatment is started and provides guidance on the need for pregnancy testing.
National specific requirements agreed with the National Competent Authority regarding:o Distribution of the product o Procedures to ensure that all appropriate measures have been performed prior to thalidomide being dispensed.
The Committee for Medicinal Products for Human Use(CHMP) concluded that,provided that very strict measures are put in place to avoid exposure of unborn children to thalidomide, Thalidomide Celgene' s benefits are greater than its risks, in combination with melphalan and prednisone as first line treatment of patients with untreated multiple myeloma, aged greater than or equal to 65 years or ineligible for high dose chemotherapy.
In patients receiving lenalidomide in combination with dexamethasone until progression or for 18 months, the hematologic SPM incidence rate(0.16 per 100 person-years)was not increased as compared to thalidomide in combination with melphalan and prednisone(0.79 per 100 person-years).
In addition, 49% of these patients responded to Velcade plus thalidomide and dexamethasone, compared with about 26% who responded to treatment containing Velcade plus other anticancer drugs, and17% who responded to thalidomide and dexamethasone alone.